Navigation Links
Brain Screenings Offered to Breast Cancer Patients During Breast Cancer Awareness Month
Date:10/19/2007

Neurologic and Orthopedic Institute of Chicago Offer Complimentary Brain

Scans, Oct 26 & 27, as Part of Clinical Study.

CHICAGO, Oct. 19 /PRNewswire/ --

What: Women diagnosed with HER-2 positive Stage III or Stage IV

breast cancer are eligible to receive an MRI of the brain

at no charge as part of a clinical trial. HER2 is a breast

cancer that tests positive for a protein called human

epidermal growth factor receptor-2 (HER2), which promotes

the growth of cancer cells. Studies have shown that in as

many as 30 percent of breast cancer patients have a

metastasis in the brain. As part of the screening

protocol, participants will undergo a MRI of the brain. The

cost of the MRI is covered by the clinical trial.

Who: Patients who qualify must have an initial primary diagnosis

of high risk and/or HER-2 positive breast cancer. They

must be at least 18 years and should not participate if

they are pregnant.

When: Friday, October 26th, 1 p.m. to 9 p.m.

Saturday, October 27th, 8 a.m. to 5 p.m.

Where: Neurologic and Orthopedic Institute of Chicago

4501 N. Winchester, Chicago

Cost: The brain MRI is free of charge to the patient.

Background: The Chicago Institute of Neurosurgery and Neuroresearch

(CINN) Medical Group will use information from the

screening to determine the potentialbenefit(s) of screening

for brain metastases in patients with advanced breast

cancer.

Study Selection & Enrollment Criteria

Women must be within three to twenty-four months of first

metastases of Stage IV diagnosis or within 12 to 24 months

of initial diagnosis of HER-2 positive Stage III disease.

They must sign a written consent form approved by the CINN

Institutional Review Board (IRB).

Exclusion criteria

Patients with a prior diagnosis of brain metastases or who

are unable to be safely exposed to MRIs. Most common

exclusions include, but are not limited to, pacemakers,

implanted defibrillators, neurostimulators, aneurysm clips,

cochlear devices, or any other institution

contraindications. Women who are pregnant.

CONTACT: Sandi Davis of Chicago Institute of Neurosurgery and Neuroresearch, 773-250-0425, http://www.cinn.org

Media Contact: Lisa Stafford, P.S. Communications, 630-986-8749, Cell: 630-212-1226, Email: lisa@pscommunicationsinc.com


'/>"/>
SOURCE Chicago Institute of Neurosurgery and Neuroresearch
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Brain death – How to cope with it
3. Multi billion-dollar suit filed against cell phone firm for causing brain tumours
4. “Brain fingerprinting”- The new lie detectr
5. Nasal Spray Could Take Drugs Direct to Brain.
6. Two doctors suspended for wrong brain surgery
7. The brain loves a surprise
8. Virus Combats Brain Tumour
9. Increase in sugar...decrease in brain function!!!
10. Alcohol shrinks brain
11. Roller coaster takes brain for a big ride!!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... , ... December 04, 2016 , ... ... major cosmetic surgery can now take advantage of a cosmetic procedure known as ... rejuvenation treatment that reduces the appearance of age spots, fine lines, uneven ...
(Date:12/4/2016)... ... December 04, 2016 , ... Responsible dental care hinges ... brush properly to achieve optimal results. This important necessity inspired an inventor from Las ... a way to ensure that people break or avoid bad techniques of brushing the ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in global ... Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New York ... who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and the ...
(Date:12/2/2016)... ... December 02, 2016 , ... On Dec. 2, 2016, CURE® magazine will host ... honoring the 2016 MPN Heroes—eight individuals who have made a difference in the field ... the standard of care, demonstrating leadership within the MPN community and/or a commitment to ...
(Date:12/2/2016)... Dothan, AL (PRWEB) , ... December 02, 2016 ... ... leaders from across the Dothan-Wiregrass Area in Alabama are expected to attend the ... Mike Schmitz, will help provide scholarship funds for area students and operating support ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec. 5, 2016 ... hydroxyurea (HU) in Complete Hematologic Response (CHR) ... ropeginterferon alfa-2b versus HU AOP will submit ... CONTINUATION-PV to obtain European marketing authorization in the coming months ... the FDA as it seeks approval for commercialization in the ...
(Date:12/4/2016)... 2016 Sickle cell disease (SCD) is an ... cells that get stuck in veins and block blood ... and complications leading to death. Each year, approximately 300,000 ... most of them lack access to comprehensive care or ... therapy for SCD, a pill called hydroxyurea approved more ...
(Date:12/2/2016)... SILVER SPRING, Md. , Dec. 2, 2016 /PRNewswire-USNewswire/ ... a new indication for Jardiance (empagliflozin) to reduce the ... 2 diabetes mellitus and cardiovascular disease. ... adults with type 2 diabetes mellitus," said Jean-Marc ... Metabolism and Endocrinology Products in FDA,s Center for Drug ...
Breaking Medicine Technology: